
Pharmacally
Atopic Dermatits
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Atopic Dermatits
Clinical TrialsConnect Biopharma Joins AAD Wave with Strong Phase 3 Rademikibart Data in Atopic DermatitsRademikibart demonstrated sustained skin clearance and a favorable safety profile through one year, positioning it as a differentiated IL-4Rα therapy in atopic dermatitis.Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.